EUA
Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test
FDA Emergency Use Authorization · Biocan Diagnostics Inc. · Aug 25, 2020
Key facts
| Product | Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test |
|---|---|
| Company | Biocan Diagnostics Inc. |
| Product type | IgM and IgG, Lateral Flow |
| Date | Aug 25, 2020 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: